In the context of dyslipidemia and inflammation, the caspase-1–inflammasome pathway in ECs can sense the elevated lipids or DAMPs and other inflammatory mediators and activate ECs (Yin et al., 2015), which is the foremost step in the progress of atherosclerosis. The gene discussed is CASP1; the disease is atherosclerosis.